News & Events about Ptc Therapeutics Inc.
PTC Therapeutics Receives 2023 EURORDIS Black Pearl Company Award for Innovation PTC Therapeutics Receives 2023 EURORDIS Black Pearl Company Award for Innovation PR Newswire SOUTH PLAINFIELD, N.J., Feb. 3, 2023 - This award recognizes PTC's 25-year legacy in discovering and delivering novel...
PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 41st Annual J.P. Morgan Healthcare Conference PR Newswire SOUTH PLAINFIELD...
The Goldman Sachs Group started coverage on shares of PTC Therapeutics (NASDAQ:PTCT Get Rating) in a research report report published on Wednesday, The Fly reports. The firm issued a sell rating and a $35.00 price target on the biopharmaceutical companys stock. A number of other ...
NEW YORK, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of PTC Therapeutics, Inc. (NASDAQ: PTCT) breached their fiduciary duties to shareholders. The investigation concerns potential self-...